| Product Code: ETC7549477 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Oncology Molecular Diagnostic Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Oncology Molecular Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 India Oncology Molecular Diagnostic Market - Industry Life Cycle |
3.4 India Oncology Molecular Diagnostic Market - Porter's Five Forces |
3.5 India Oncology Molecular Diagnostic Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Oncology Molecular Diagnostic Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 India Oncology Molecular Diagnostic Market Revenues & Volume Share, By Test Location, 2021 & 2031F |
3.8 India Oncology Molecular Diagnostic Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 India Oncology Molecular Diagnostic Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Oncology Molecular Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in India |
4.2.2 Rising awareness about early cancer detection and personalized medicine |
4.2.3 Technological advancements in molecular diagnostics |
4.3 Market Restraints |
4.3.1 High cost associated with molecular diagnostic tests |
4.3.2 Limited access to advanced healthcare facilities in rural areas |
4.3.3 Regulatory challenges and approval processes for molecular diagnostic tests |
5 India Oncology Molecular Diagnostic Market Trends |
6 India Oncology Molecular Diagnostic Market, By Types |
6.1 India Oncology Molecular Diagnostic Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Oncology Molecular Diagnostic Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 India Oncology Molecular Diagnostic Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.1.4 India Oncology Molecular Diagnostic Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.1.5 India Oncology Molecular Diagnostic Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.1.6 India Oncology Molecular Diagnostic Market Revenues & Volume, By Cervical Cancer, 2021- 2031F |
6.1.7 India Oncology Molecular Diagnostic Market Revenues & Volume, By Liver Cancer, 2021- 2031F |
6.1.8 India Oncology Molecular Diagnostic Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.1.9 India Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 India Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Oncology Molecular Diagnostic Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 India Oncology Molecular Diagnostic Market Revenues & Volume, By Instruments, 2021- 2031F |
6.2.3 India Oncology Molecular Diagnostic Market Revenues & Volume, By Reagents, 2021- 2031F |
6.2.4 India Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Oncology Molecular Diagnostic Market, By Test Location |
6.3.1 Overview and Analysis |
6.3.2 India Oncology Molecular Diagnostic Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.3 India Oncology Molecular Diagnostic Market Revenues & Volume, By Other Establishments, 2021- 2031F |
6.3.4 India Oncology Molecular Diagnostic Market Revenues & Volume, By Point of Care, 2021- 2031F |
6.4 India Oncology Molecular Diagnostic Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 India Oncology Molecular Diagnostic Market Revenues & Volume, By PCR, 2021- 2031F |
6.4.3 India Oncology Molecular Diagnostic Market Revenues & Volume, By Multiplex, 2021- 2031F |
6.4.4 India Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.4.5 India Oncology Molecular Diagnostic Market Revenues & Volume, By In Situ Hybridization, 2021- 2031F |
6.4.6 India Oncology Molecular Diagnostic Market Revenues & Volume, By Isothermal Nucleic Acid Amplification Technology (INAAT), 2021- 2031F |
6.4.7 India Oncology Molecular Diagnostic Market Revenues & Volume, By Chips and Microarrays, 2021- 2031F |
6.4.8 India Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.4.9 India Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.5 India Oncology Molecular Diagnostic Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 India Oncology Molecular Diagnostic Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 India Oncology Molecular Diagnostic Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
7 India Oncology Molecular Diagnostic Market Import-Export Trade Statistics |
7.1 India Oncology Molecular Diagnostic Market Export to Major Countries |
7.2 India Oncology Molecular Diagnostic Market Imports from Major Countries |
8 India Oncology Molecular Diagnostic Market Key Performance Indicators |
8.1 Adoption rate of molecular diagnostic tests in oncology |
8.2 Number of research and development initiatives in oncology molecular diagnostics |
8.3 Rate of integration of molecular diagnostics in cancer treatment protocols |
8.4 Patient outcomes improvement based on molecular diagnostic results |
8.5 Number of partnerships and collaborations for expanding molecular diagnostic services in India |
9 India Oncology Molecular Diagnostic Market - Opportunity Assessment |
9.1 India Oncology Molecular Diagnostic Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Oncology Molecular Diagnostic Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 India Oncology Molecular Diagnostic Market Opportunity Assessment, By Test Location, 2021 & 2031F |
9.4 India Oncology Molecular Diagnostic Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 India Oncology Molecular Diagnostic Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Oncology Molecular Diagnostic Market - Competitive Landscape |
10.1 India Oncology Molecular Diagnostic Market Revenue Share, By Companies, 2024 |
10.2 India Oncology Molecular Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here